Register Now – Use code FE21 for a $100 discount on your registration! Please enter the code on the payment page.
CfPA is the premiere, accredited, global training-provider for professionals in the life sciences and allied industries. We are powered by our passion and mission to improve our customers skills and enhance their knowledge through high quality technical training. It’s why more than 500,000 professionals and tens of thousands of companies have trust CfPA with their careers and training programs.
We offer a comprehensive curriculum of Virtual, Online, Customized Team Training, and In Person, courses from introductory to advanced topics. Our training is ideal for those in Quality, Compliance, R&D, Validation, Development, Manufacturing, Production, Engineering, Packaging, and more.
For over 50 years CfPA has set the standard for training excellence, we pride ourselves for being technology forward in continually updating and upgrading our training experience to meet, and exceed, the needs of our customers.
Who Should Attend?
This is an in-depth course with hands on experience intended for product development scientists and technologists and support groups concerned with the development, designing and processing of tablets and similar oral products.
The material will be presented in such a way as to be of value to a varying level of expertise. This course will especially benefit those in:
- Formulation Development
- Quality Assurance (Formulation Development Support staff)
- Research and Development
- Validation
- Regulatory Affairs (CMC Writers)
- Manufacturing /Production
Course Description
Course Director |
|
Dr. Cecil W. Propst, Managing Director, Propst Consulting Services |
Dr. Cecil W. Propst is Managing Director at Propst Consulting Services, a formulation, and engineering support LLC located in Norton Shores MI. He was Director of R&D (Grand Haven site) at SPI Pharma until 2015. He served as Director of Quality Assurance and Technical Services at Fleming and Company, and before that, President of Manufacturing Chemists. His duties included system design, product and process development and regulatory affairs. Previously, he served as cGMP Facilities Director for the University of Maryland at Baltimore, in connection with the University’s SUPAC contract with the FDA. Dr. Propst also served as Director of Technical Development for Stellar Manufacturing; Director of Quality Compliance for SmithKline Beecham; Director, Quality Assurance for Norcliff Thayer (a Revlon Company); and Group Leader/Product Development and Manager/Quality Control for Lewis Howe Company. He serves as a consultant in the area of product development and process investigations for the chemical, diagnostic, food, engineering and beverage industries.
Course Director |
|
Dilip Parikh, President and CEO, DPharma Group Inc. |
Dilip M. Parikh is the President and CEO of DPharma Group Inc., a Pharmaceutical Technology consulting organization. He has over 45 years of varied experience in the pharmaceutical industry which ranges from product development, manufacturing, regulatory affairs, and operational & executive management, gained at Sandoz (Canada), McNeil and Ortho Pharmaceutical (Johnson & Johnson family of companies) in Canada and the US, and other pharmaceutical companies. He is the Editor of the book Handbook of Pharmaceutical Granulation Technology (1997, Marcel Dekker, NY). Second edition published in September 2005 (Taylor and Francis, Publisher); Third edition in 2009 (Taylor and Francis, Publisher) and the Fourth edition in 2021 (CRC Press, Publisher) and the author of “How to Optimize Fluid Bed Processing Technology” (2007, Academic Press Elsevier, Publisher)
ADDITIONAL FACULTY
Joel Light is Principal Scientist at TEAM Pharma, a formulation development, clinical supply, and contract manufacturing company.
Accreditations
IACET – The Center for Professional Advancement has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 11130 Sunrise Valley Drive, Suite 350, Reston, VA 20191. In obtaining this approval, The Center for Professional Advancement has demonstrated that it complies with the ANSI/IACET Standards which are widely recognized as standards of good practice internationally. The Center for Professional Advancement is therefore authorized to offer IACET CEUs for its programs that qualify under the ANSI/IACET Standards. CEU will be awarded for participation in The Center for Professional Advancement’s courses at the rate of .1 CEU per contact hour. CEU will be awarded only upon successful completion of the entire course and 70% accuracy in the required Learners’ Assessment. This course offers a total of 12 contact hours or 1.2 CEUs.
CfPA IN PERSON HEALTH & SAFETY POLICY
Our staff and attendee’s health and safety is always a top priority. All registrants attending this event will be required to show proof of full COVID-19 vaccination or a negative COVID-19 test to be admitted to the course.
You will need to present ONE of the following:
- Proof of full COVID-19 vaccination (must be at least 14 days after your second dose of vaccine or single dose of Johnson & Johnson prior to the course you are attending). Proof accepted includes: original vaccination card or printed copy, photo of vaccination card on smartphone, vaccination passport service or app (such as Common Pass, Clear Health Pass)
- Proof of negative results from a COVID-19 test taken within 72 hours of the event that was administered by a clinician (PCR or rapid antigen)
An appropriate ID matching the name of either the above documentation will also need to be shown to enter the course.
Note: No entry into the course if you are unable to provide the appropriate proof of vaccine or negative test results at time of the course.
Venue Information
Federal Equipment Company
2917 E. 79th Street
Cleveland, OH , OH 44101
PLEASE NOTE: Participants must make their own reservations; the cost of hotel accommodation is not included in the course fee. Final hotel information will be emailed to you in your confirmation package approximately 3 weeks prior to the course start date.
Solid oral dosage forms, or more commonly tablets, are the most common type of dosage form for pharmaceutical and nutraceutical products. Yet, what may appear to the eye as just a very simple tablet can be fraught with hidden complexities. There are many different ways to manufacture these products starting with the appropriate selection of excipients all the way through the production of the finished product. Ultimately, the successful production of a tablet is dependent upon the knowledge and expertise of the developers, formulators, and production staff.